{"transactions":[{"id":688229,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23756,"kind":"organization","name":"Sanitam Partners LLC","position":1,"cik":"0002056830","reported_name":"Sanitam Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Stock","published_at":"2026-08-13T20:01:59.000Z","date":"2026-06-10","kind":"other","planned":false,"acquired":false,"shares":4798636,"price":0.6446,"value":3093200.7656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 10, 2026, Sanitam Parnters LLC (\"Sanitam\") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant."}],"balance_after":0,"derivative":{"exercise_price":0.6446,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock","underlying_shares":4798636},"source":{"system":"sec-edgar","filing":"0000921895-26-002105","document":"form413617016san_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056830/000092189526002105/form413617016san_08132026.xml","form_type":"4"}},{"id":688228,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23756,"kind":"organization","name":"Sanitam Partners LLC","position":1,"cik":"0002056830","reported_name":"Sanitam Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-08-13T20:01:59.000Z","date":"2026-06-10","kind":"other","planned":false,"acquired":false,"shares":1406,"price":0.586,"value":823.916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On June 10, 2026, Sanitam Parnters LLC (\"Sanitam\") distributed its holdings in the Registrant's preferred stock and warrants to its members. As such Sanitam no longer beneficially owns any securities of the Registrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C Convertible Preferred Stock of the Registrant is perpetual and has no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0.586,"exercise_date":"2025-04-04","underlying":"Common Stock","underlying_shares":2399318},"source":{"system":"sec-edgar","filing":"0000921895-26-002105","document":"form413617016san_08132026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056830/000092189526002105/form413617016san_08132026.xml","form_type":"4"}},{"id":1174239,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23756,"kind":"organization","name":"Sanitam Partners LLC","position":1,"cik":"0002056830","reported_name":"Sanitam Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2025-04-10T20:45:03.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":2399318,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Sanitam purchased an aggregate of 1,406 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the \"Preferred Stock\") with a stated value of $1,000 per share of Preferred Stock, and 4,798,636 Warrants for gross proceeds of $1,406,000.00. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 703 shares of Preferred Stock and 2,399,318 Warrants."}],"balance_after":4798636,"derivative":{"exercise_price":0.6446,"exercise_date":"2025-04-08","expiration_date":"2030-04-08","underlying":"Common Stock","underlying_shares":2399318},"source":{"system":"sec-edgar","filing":"0001477932-25-002594","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2056830/000147793225002594/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-28"}},{"id":1174238,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":23756,"kind":"organization","name":"Sanitam Partners LLC","position":1,"cik":"0002056830","reported_name":"Sanitam Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-04-10T20:45:03.000Z","date":"2025-04-08","kind":"purchase","planned":false,"acquired":true,"shares":703,"price":1000,"value":703000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Securities Purchase Agreement, dated February 13, 2025, Sanitam purchased an aggregate of 1,406 shares of the Issuer's Series C Convertible Preferred Stock, par value $0.0001 per share (the \"Preferred Stock\") with a stated value of $1,000 per share of Preferred Stock, and 4,798,636 Warrants for gross proceeds of $1,406,000.00. The Preferred Stock and Warrants were sold in two tranches with each tranche consisting of 703 shares of Preferred Stock and 2,399,318 Warrants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"N/A"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each holder of Preferred Stock is entitled to vote on an as-converted to Common Stock basis with a per share voting price of $0.6393, granting Sanitam voting power from the Preferred Strock of up to 30.2% of the outstanding Common Stock. Sanitam's beneficial ownership is subject to a 9.99% limit on the shares of Common Stock issuable upon conversion of the Preferred Stock and a 4.99% limit on the shares of Common Stock issuable upon exercise of the Warrants."}],"balance_after":1406,"derivative":{"exercise_price":0.586,"exercise_date":"2025-04-04","underlying":"Common Stock","underlying_shares":1199659},"source":{"system":"sec-edgar","filing":"0001477932-25-002594","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2056830/000147793225002594/form4a.xml","form_type":"4/A","original_submission_date":"2025-02-28"}}]}